<html><head></head><body><h1>Tetracaine Ophthalmic Solution</h1><p class="drug-subtitle"><b>Generic Name:</b> tetracaine hydrochloride<br/>
<b>Dosage Form:</b> ophthalmic solution<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Professional</li>
<li>Interactions</li>
<li>Breastfeeding</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Indications and Usage</li>
<li>Dosage and Administration</li>
<li>Dosage Forms and Strengths</li>
<li>Contraindications</li>
<li>Warnings and Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li>Use In Specific Populations</li>
<li class="ddc-toggle-hidden">Overdosage</li>
<li class="ddc-toggle-hidden">Description</li>
<li class="ddc-toggle-hidden">Clinical Pharmacology</li>
<li class="ddc-toggle-hidden">Nonclinical Toxicology</li>
<li class="ddc-toggle-hidden">Clinical Studies</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
<li class="ddc-toggle-hidden">Patient Counseling Information</li>
</ul><h2>Indications and Usage for Tetracaine Ophthalmic Solution</h2><p class="First">Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic.</p><h2>Tetracaine Ophthalmic Solution Dosage and Administration</h2><p class="First">One drop topically in the eye(s) as needed.</p><h2>Dosage Forms and Strengths</h2><p class="First">Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is a clear, colorless, ophthalmic solution containing 0.5% w/v tetracaine hydrochloride equivalent to tetracaine 0.44% w/v.</p><h2>Contraindications</h2><p class="First">Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% should not be used in patients with a history of hypersensitivity to any component of this preparation.</p><h2>Warnings and Precautions</h2><h3>Corneal Injury with Intracameral Use</h3><p class="First">Not for injection or intraocular use. Do not use intracamerally because use of Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% may lead to damage of the corneal endothelial cells.</p><h3>Corneal Toxicity</h3><p class="First">Prolonged use or abuse may lead to corneal epithelial toxicity and may manifest as epithelial defects which may progress to permanent corneal damage.</p><h3>Corneal Injury due to Insensitivity</h3><p class="First">Patients should not touch the eye for at least 10-20 minutes after using anesthetic as accidental injuries can occur due to insensitivity of the eye.</p><h2>Adverse Reactions</h2><p class="First">The following serious ocular adverse reactions are described elsewhere in the labeling:</p><p>The following adverse reactions have been identified following use of Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5%. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</p><p><span class="Bold">Ocular Adverse Reactions</span></p><p>Transient stinging, burning, and conjunctival redness, eye irritation, eye pain, ocular discomfort.</p><h2>USE IN SPECIFIC POPULATIONS</h2><h3>Pregnancy</h3><p class="First"><span class="Bold"><span class="Bold">Risk Summary</span></span></p><p>There are no adequate and well-controlled studies with Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% in pregnant women. Animal developmental and reproductive toxicity studies with tetracaine hydrochloride have not been reported in the published literature.</p><h3>Lactation</h3><p class="First"><span class="Bold"><span class="Bold">Risk Summary</span></span></p><p>There are no data to assess whether Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is excreted in human milk or to assess its effects on milk production/excretion. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% and any potential adverse effects on the breastfed child from Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5%.</p><h3>Females and Males of Reproductive Potential</h3><p class="First">No human data on the effect of Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% on fertility are available.</p><h3>Pediatric Use</h3><p class="First">Safety of Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% in the pediatric population has been demonstrated in clinical trials. Efficacy of Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% for use in pediatric patients has been extrapolated from adequate and well controlled clinical trials in the adult population.</p><h3>Geriatric Use</h3><p class="First">No overall differences in safety or effectiveness of Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% have been observed between elderly and younger patients.</p><h2>Overdosage</h2><p class="First">Prolonged use of a topical ocular anesthetic including Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% may produce permanent corneal opacification and ulceration with accompanying visual loss.</p><h2>Tetracaine Ophthalmic Solution Description</h2><p class="First">Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is a sterile, clear, colorless, topical local anesthetic for ophthalmic use only containing tetracaine hydrochloride as the active pharmaceutical ingredient.</p><p>Tetracaine hydrochloride is chemically designated as benzoic acid, 4-(butylamino)-,</p><p>2-(dimethylamino) ethyl ester, monohydrochloride. Its chemical formula is C15H24N2O2 •</p><p>HCl and it is represented by the chemical structure:</p><p>Tetracaine hydrochloride is a fine, white, crystalline, odorless powder with a molecular weight of</p><p>300.82</p><p><span class="Bold">Active ingredient</span>: tetracaine hydrochloride 0.5% w/v (equivalent to 0.44% w/v tetracaine)</p><p><span class="Bold">Preservative</span>: chlorobutanol 0.4%</p><p><span class="Bold">Inactive ingredients</span>: boric acid, potassium chloride, edetate disodium dihydrate, water for injection.</p><p>Sodium hydroxide and/or hydrochloric acid may be added to adjust pH (3.7 – 6.0).</p><h2>Tetracaine Ophthalmic Solution - Clinical Pharmacology</h2><h3>Mechanism of Action</h3><p class="First">Tetracaine blocks sodium ion channels required for the initiation and conduction of neuronal impulses thereby affecting local anesthesia.</p><h3>Pharmacokinetics</h3><p class="First">The systemic exposure to tetracaine following topical ocular administration of Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% has not been studied. Tetracaine hydrochloride is metabolized by plasma pseudocholinesterases and nonspecific esterases in ocular tissues.</p><h2>Nonclinical Toxicology</h2><h3>Carcinogenesis, Mutagenesis, Impairment of Fertility</h3><p class="First">Studies to assess the genotoxicity of tetracaine hydrochloride have not been reported in the published literature. Long-term animal studies have not been conducted to evaluate the carcinogenic potential of tetracaine hydrochloride. Animal studies to assess the effects of tetracaine hydrochloride on fertility have not been reported in the published literature.</p><h2>Clinical Studies</h2><p class="First">Topical administration of Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% results in localized temporary anesthesia. The maximum effect is achieved within 10–20 seconds after instillation, with efficacy lasting 10–20 minutes. Duration of effect can be extended with repeated dosing. [See Warnings and Precautions (5.2) and Overdosage (10)].</p><h2>How Supplied/Storage and Handling</h2><p class="First">Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is supplied as a sterile, aqueous, topical ophthalmic solution in a low-density polyethylene plastic dropper bottle with a low-density polyethylene dropper tip and white polypropylene cap in the following sizes:</p><p>After opening, this product can be used until the expiration date stamped on the bottle.</p><p><span class="Bold">Storage</span>: Store at 15° to 25°C (59° to 77°F). Protect from light. Do not use if solution contains crystals, cloudy, or discolored.</p><h2>Patient Counseling Information</h2><p class="First"><span class="Bold">Eye Care Precaution</span></p><p>Do not touch the dropper tip to any surface as this may contaminate the solution.</p><p>Advise patients that, due to the effect of the anesthetic, their eyes will be insensitive for up to 20 minutes and that care should be taken to avoid accidental injuries.</p><p><span class="Bold">Distributed by:</span></p><p>Bausch Health US, LLC<br/>
Bridgewater, NJ 08807 USA</p><p><span class="Bold">Manufactured by:</span></p><p>Bausch &amp; Lomb Incorporated<br/>
Tampa, FL 33637 USA</p><p>© 2020 Bausch Health Companies Inc. or its affiliates</p><p>9xxxxxx (Folded)<br/>
9xxxxxx (Flat)</p><h2>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL- Carton 5 mL</h2><p class="First"><span class="Bold">NDC</span> 0187-0920-05</p><p><span class="Bold">Rx only</span></p><p><span class="Bold">Tetracaine</span><br/>
<span class="Bold">Hydrochloride</span></p><p><span class="Bold">Ophthalmic</span><br/>
<span class="Bold">Solution, USP</span><br/>
<span class="Bold">0.05% (Sterile)</span></p><p><span class="Bold">5 mL</span></p><p><span class="Bold">BAUSCH Health</span></p><h2>More about tetracaine ophthalmic</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>Breastfeeding</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>Drug class: ophthalmic anesthetics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Tetracaine (Ophthalmic) &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Professional Patient Advice)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>